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Development/Plasticity/Repair
Heparan Sulfotransferases Hs6st1 and Hs2st Keep Erk in
Check for Mouse Corpus Callosum Development
James M. Clegg,1 Christopher D. Conway,1 Kathy M. Howe, David J. Price,1 John O. Mason,1 Jeremy E. Turnbull,2
M. Albert Basson,3 and Thomas Pratt1
1Centre for Integrative Physiology, The University of Edinburgh, Edinburgh EH8 9XD, United Kingdom, 2Centre for Glycobiology, Institute of Integrative
Biology, University of Liverpool, Liverpool L69 7ZB, United Kingdom, and 3Department of Craniofacial Development and Stem Cell Biology, King’s College
London, London SE5 9RW, United Kingdom
The corpus callosum (CC) connects the left and right cerebral hemispheres in mammals and its development requires intercellular
communication at the telencephalic midline mediated by signaling proteins. Heparan sulfate (HS) is a sulfated polysaccharide that
decorates cell surface and extracellular matrix proteins and regulates the biological activity of numerous signaling proteins via sugar–
protein interactions. HS is subject to regulated enzymatic sulfation and desulfation and an attractive, although not proven, hypothesis is
that the biological activity of HS is regulated by a sugar sulfate code.Mutantmouse embryos lacking the heparan sulfotransferasesHs2st
or Hs6st1 have severe CC phenotypes and form Probst bundles of noncrossing axons flanking large tangles of midline glial processes.
Here, we identify a precocious accumulation of Sox9-expressing glial cells in the indusiumgriseumregion and a corresponding depletion
at the glial wedge associated with the formation of Probst bundles along the rostrocaudal axis in both mutants. Molecularly, we found a
surprising hyperactivation of Erk signaling in Hs2st / (2-fold) and Hs6st1 / (6-fold) embryonic telencephalon that was most
striking at themidline, where Erk signaling is lowest inwild-types, and a 2-fold increase in Fgf8 protein levels inHs6st1 / embryos that
could underpin Erk hyperactivation and excessive glial movement to the indusium griseum. The tightly linked Hs6st1 / CC glial and
axonal phenotypes can be rescued by genetic or pharmacological suppression of Fgf8/Erk axis components. Overall, our data fit a model
inwhichHs2st andHs6st1normally generate conditions conducive toCCdevelopment by generating anHS-containing environment that
keeps Erk signaling in check.
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Introduction
The corpus callosum (CC) is the largest mammalian axon tract
and mounting evidence links abnormal CC development with
neuropsychological effects (Richards, 2002; Bedeschi et al., 2006;
Paul et al., 2007; Donahoo and Richards, 2009; Fame et al., 2011).
Secreted signaling proteins of the Fgf, Bmp, andWnt families act
through the Erk, Smad, and Tcf/Lef pathways at the corticoseptal
boundary (CSB) to generate neuronal and glial structures, a key
event being glial translocation from the glial wedge (GW) to the
indusium griseum (IG) (Smith et al., 2006; Tole et al., 2006;
Niquille et al., 2009; Moldrich et al., 2010; Sa´nchez-Camacho et
al., 2011; Benadiba et al., 2012; Magnani et al., 2013; Amaniti et
al., 2013; Niquille et al., 2013). These structures secreteWnt, Slit,
Sema, Bmp, Draxin, and Netrin proteins, which guide CC
axons (CCAs) across the midline from embryonic day 16.5
(E16.5) (Serafini et al., 1996; Bagri et al., 2002; Wang et al.,
2002; Shu et al., 2003b; Keeble et al., 2006; Lo´pez-Bendito et
al., 2007; Islam et al., 2009; Niquille et al., 2009; Choe et al.,
2012; Fothergill et al., 2013).
Heparan sulfate proteoglycans are cell surface and secreted gly-
coproteins with heparan sulfate (HS) sidechains (polysaccharides)
that are enzymatically sulfated (by specificN-, 2O-, 3O- and 6O-
sulfotransferases [STs]) and 6-O-desulfated (by 6-O-sulfatases,
Sulfs). The “sugar code” hypothesis proposes that the biological
activity of HS is encoded in its sulfation patterns (Allen et al.,
2001; Merry et al., 2001; Turnbull et al., 2001; Powell et al., 2002;
Allen and Rapraeger, 2003; McLaughlin et al., 2003; Bu¨low and
Hobert, 2004; Lee and Chien, 2004; Grobe et al., 2005; Holt and
Dickson, 2005; Kinnunen et al., 2005; Kreuger et al., 2006; Pan et
al., 2006; Pratt et al., 2006; Bu¨low et al., 2008; Pan et al., 2008;
Conway et al., 2011a; Conway et al., 2011b; Qu et al., 2011).
Mutations affecting HS synthesis or sulfation cause CC phe-
notypes (Inatani et al., 2003; Grobe et al., 2005; Kalus et al., 2009;
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Conway et al., 2011a). The heparan sulfotransferases Hs2st
(which place O-sulfates at the 2-position of uronic acid) and
Hs6st1 (which placeO-sulfates at the 6-position ofN-acetylated/
N-sulfated glucosamines) are expressed widely and at varying
levels in the developing telencephalon, including strong expres-
sion in theGWand IG at theCSB (Pratt et al., 2006; Conway et al.,
2011a). Hs2st / and Hs6st1 / embryos have severe CC phe-
notypes in which large tangles of glial processes block the path of
CCAs at the telencephalic midline, causing Probst bundle (PB)
formation with a more penetrant phenotype in Hs6st1 / em-
bryos (Conway et al., 2011a). Here, we reveal how mutations in
Hs2st orHs6st1 affect signaling pathways critical for CC develop-
ment. We observe increased GW3 IG glial movement in
Hs2st / and Hs6st1 / embryos, increased Fgf8 protein in
Hs6st1 / embryos, and hyperactive Erk signaling in both mu-
tants, with greater hyperactivation in Hs6st1 / embryos. We
develop the hypothesis that Hs6st1 and Hs2st normally suppress
Erk signaling in the GW and that desuppression of Erk in
Hs2st / andHs6st1 / embryos causes the phenotype.We test
this by suppressing Fgf8/Erk axis components genetically or phar-
macologically in Hs6st1 / embryos and, as predicted, amelio-
rate phenotype severity.
Materials andMethods
Animals. All mice were bred in-house in line with Home Office UK
legislation. The licenses authorizing this work were approved by theUni-
versity of Edinburgh and King’s College London Ethical Review Com-
mittees and by the Home Office. Animal husbandry was in accordance
with the UK Animals (Scientific Procedures) Act 1986 regulations.
The Hs2stLacZ (Hs2st) mutant allele was obtained by insertion of a
LacZ gene trap vector into the Hs2st locus (Bullock et al., 1998) and the
Hs6st1LacZ - ires - hPLAP (Hs6st1)mutant allele by insertion of a LacZires-
hPLAP gene trap vector into intron 1 of theHs6st1 locus (Mitchell et al.,
2001). The Hs2st and Hs6st1 alleles were maintained on an inbred
CBA background;Hs2st / and Hs6st1 / embryos were obtained by
crossing heterozygous (Hs2st/ orHs6st1/) animals. Genotyping of
Hs2st andHs6st1 animals was performed by PCR as described previ-
ously (Conway et al., 2011a). The Fgf8LacZ (Fgf8) mutant allele (Ilagan
et al., 2006) was maintained on a C57BL/6J inbred background. For the
Hs6st1/Fgf8 rescue experiments, we crossed Hs6st1/ (CBA inbred
genetic background) with Fgf8/ (C57BL/6J inbred genetic back-
ground) to generate Hs6st1/;Fgf8/ compound heterozygotes (F1:
CBAxC57BL/6J). To obtain Hs6st /;Fgf8/ embryos, Hs6st/;
Fgf8/ animals were crossed and the resultant embryos (F2) were of a
mixed CBAxC57BL/6J genetic background. Because variable penetrance
is a common property of CC phenotypes (Keeble et al., 2006; Smith et al.,
2006; Conway et al., 2011a; Bohlen et al., 2012), we confirmed that the
Hs6st1 / phenotype is indeed fully penetrant (13/13 embryos; Fig. 7A)
inHs6st1 /;Fgf8/ F2:CBAxC57BL/6J genetic background embryos.
BrdU injection. Bromodeoxyuridine (BrdU; Sigma) was dissolved in
PBS at a concentration of 10 mg/ml. Pregnant females were injected
intraperitoneally with 200l of BrdU at E14.5. Females were then culled
at E16.5 and embryonic brains were dissected and processed for immu-
nohistochemistry.
qRT-PCR. RNA was extracted from medial telencephalon tissue at
E16.5 using theRNAeasyMiniKit (Qiagen). First-strand cDNA synthesis
was performed using oligo (dT) primers (Promega) with a Sensiscript Re-
verse Transcriptase kit (Qiagen). qRT-PCR was performed on cDNA using
the following primer pairs: FGF8 5-TGGAAGCAGAGTCCGAGTTC-3
and 5-TGTGAATACGCAGTCCTTGC-3 and GAPDH 5-GGGT-
GTGAACCACGAGAAAT-’3and5-CCTTCCACAATGCCAAAGTT-
3. qRT-PCR was performed using a Quantitect Sybr Green PCR kit
(Qiagen). PCR was performed using an MJ Research Opticon Light Cy-
cler and the abundance of each transcript (relative to GAPDH) was cal-
culated using Opticon software and Microsoft Excel.
MEK inhibitor treatment. TheMEK inhibitor PD0325901 (Sigma) was
dissolved in DMSO at a concentration of 25 mg/ml and suspended in
0.5% hydroxypropylmethyl-cellulose (Sigma) plus 0.2% Tween 80
(Sigma) to give a final inhibitor concentration of 0.5mg/ml.MEK inhib-
itor was administered to pregnant females by intraperitoneal injection at
a concentration of 5 mg/kg body weight daily from 14.5 to 17.5 d after
fertilization. Embryos were then dissected at E18.5 and MEK-inhibitor-
treated Hs6st / embryos were compared with vehicle-injected con-
trols. This protocol was adapted from one used previously (Wang et al.,
2012).
Immunohistochemistry. Embryonic mouse brains were dissected at
E16.5, E17.5, or E18.5 and fixed overnight in 4% paraformaldahyde in
PBS at 4°C. Brainswere then either dehydrated and embedded in paraffin
wax or cryoprotected using 30% sucrose in PBS and embedded in OCT
for cryosectioning. Paraffin-embedded brains were sectioned coronally
at 10 m using a microtome (Leica) and frozen brains were sectioned
coronally using a cryostat (Leica) at 10 m. Cut sections were mounted
serially on Superfrost Plus slides (Fisher Scientific) and allowed to dry.
Paraffin-embedded sections were dewaxed using xylene and rehy-
drated through an ethanol series. Sections were then boiled in 10 mM
sodium citrate to aid epitope recovery. After a wash in PBS, sections were
treated with blocking solution (20% goat serum in 0.1% Triton X-100/
PBS) and incubated with the primary antibody diluted in blocking solu-
tion overnight at 4°C. Primary antibodies used were rabbit anti-LEF1
(1/100; Cell Signaling Technology), mouse anti-phospho-histone 3 (1/100;
Cell Signaling Technology), mouse anti-phospho-MAPK1/2 (pErk1/2,
1/200; Cell Signaling Technology) and rabbit anti-phospho-SMAD1/5 (1/
50; Cell Signaling Technology). Sections were then washed with PBS and
incubated with a biotinylated secondary antibody (goat anti-mouse bio-
tin or goat anti-rabbit biotin, both Vector Laboratories) diluted 1/200 in
blocking solution. After washing with PBS, antibody staining was visual-
ized using a standard avidin-biotin diaminobenzidine (DAB) detection
procedure (Vector Laboratories). After DAB staining, sections were de-
hydrated and mounted in DPX. Bright-field images of DAB-stained sec-
tions were captured using a Leica DLMB microscope coupled to a
DFC480 color digital camera.
Frozen sections were washed with 0.1% Triton X-100 in PBS and
treated with the blocking solution (20% goat serum, 1% BSA in 0.1%
Triton X-100/PBS). Sections were incubated with the primary anti-
body diluted in blocking solution overnight at 4°C. Primary antibod-
ies used were mouse anti-NeuN (1/500; Millipore), rabbit anti-Sox9
(1/200; Millipore), rabbit anti-Tbr1 (1/200, gift from Robert Hevner),
mouse anti-Fgf8 (1/5000; R&D Systems), rat anti-L1 (1/500; Millipore),
rabbit anti-GFAP (1/100; Dako), and mouse anti-BrdU (1/100; BD Bio-
sciences). Sections were washed with PBS and incubated with the appro-
priate secondary antibody diluted in blocking solution for 1 h at room
temperature. Secondary antibodies used were goat anti-mouse Alexa
Fluor 568, goat anti-rabbit Alexa Fluor 488, goat anti-rabbit Alexa Fluor
568, and goat anti-rat Alexa Fluor 568 (all used 1/200 and all from Invit-
rogen). Sections were counterstained with DAPI (Invitrogen) diluted
1/1000 in PBS and mounted using Vectashield Hardset H1400 (Vector
Laboratories). To detect Fgf8, the above procedure was used but a TSA
Plus Fluorescence System kit (PerkinElmer) was used in place of anAlexa
Fluor secondary antibody. Fluorescent imageswere capturedwith a Leica
AF6000 epifluorescence microscope connected to a DFC360 digital
camera.
In situ hybridization. In situ hybridization was performed on frozen
sections as described previously (Wallace and Raff, 1999) using a
digoxigenin-labeled antisense riboprobe for Fgf8 (kindly provided by J.
Rubenstein).
Quantification of cell number. To quantify the number of Sox9- and/or
BrdU-immunofluorescent positive cells at the IG region of wild-type,
Hs2st /, andHs6st1 / brains (Figs. 2, 3), a counting box measuring
250 m  250 m was placed on images of sections at the midline
directly ventral to the ventral-most extent of the Tbr1 expression domain
that marks the dorsal boundary of the IG (Fig. 1). The presence or ab-
sence of the corpus callosum or PBs within the section was noted in each
section. To quantify the number of Sox9-immunofluorescence-positive
cells within a strip of cells from the GW to the IG (Figs. 2, 8), a 100-m-
wide rectangle was placed on images extending from the ventricular zone
of the GW to the pial surface adjacent to the IG. The rectangle was placed
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directly ventral to the ventral-most extent of the Tbr1 expression domain
as above. The counting boxwas then divided into a GWand IG compart-
ment. For each genotype, three animals were analyzed and, for each
animal, three sections were analyzed (a rostral, middle, and caudal sec-
tion). The rostrocaudal position of sections was determined as above.
Western blotting. Whole telencephali were dissected at E16.5 and lysed
using RIPA lysis buffer (Sigma) on ice for 30 min. The lysate was then
resolved on a 4–12% bis-tris gel (Invitrogen) and transferred to a nitro-
cellulosemembrane (Bio-Rad). Themembranewas blocked using block-
ing solution (Li-Cor) and blotted overnight using the following primary
antibodies: mouse anti-phosho-MAPK1/2 (1/1000; Cell Signaling Tech-
nology), mouse anti-MAPK1/2 (1/2000; Cell Signaling Technology),
mouse anti-Fgf8 (1/1000, R&D Systems), rabbit anti-LEF1 (1/1000; Cell
SignalingTechnology), and rabbit anti-phospho-SMAD1/5 (1/2000; Cell
Signaling Technology). For each blot performed, themembrane was also
probed using an antibody for-actin (mouse anti--actin or rabbit anti-
-actin, both used 1/5000 and both from Abcam) that acted as a loading
control. The membrane was incubated for 2 h with the secondary anti-
bodies, goat anti-mouse Alexa Fluor 680 (Invitrogen), and goat anti-
rabbit 800 (Li-Cor). Blots were quantified using the Li-Cor scanning
system. In each case, protein levels were normalized to -actin level
detected on the same membrane.
Transfection of Cos7 cells. Cos7 cells were transfected with a cDNA
expression construct expressing full-length mouse Fgf8 protein (nt201–
845, GenBank accessionNM_001166362)with aC-terminalmyc epitope
tag using a pSecTag2 vector (Invitrogen) that had been modified to re-
move the Ig secretory signal.
Results
Sox9 glial cells overpopulate the IG at the expense of the
GW inHs2st / andHs6st1 / embryonic telencephalon
We previously reported striking embryonic corpus callosum
agenesis and PB formation inHs2st / andHs6st1 /mice that
appeared to be caused by abnormal orga-
nization of glial cells during development
(Conway et al., 2011a). To shed a more
quantitative light on the glial Hs2st /
andHs6st1 / phenotypes, we accurately
quantified glial cells using Sox9, a tran-
scription factor expressed both in radial
glial cell (RGC) progenitors and inmature
glia but switched off during neuronal dif-
ferentiation, as a glial cell nuclear marker
(Pompolo andHarley, 2001; Kordes et al.,
2005; Nowakowski et al., 2013). At the tel-
encephalic midline, Sox9 marks RGCs in
the ventricular zone (VZ) and glia in the
GW and IG (Fig. 1). Double labeling
E17.5 wild-type embryos with Sox9 and
the neuronal nuclear transcription factors
NeuN (Fig. 1A,B) or Tbr1 (Fig. 1C)
showed large numbers of Sox9-expressing
(hereafter referred to as Sox9) cells in
the VZ/GWand a small tight cluster in the
IG region ventral to Tbr1/NeuN-positive
cells (Fig. 1A–C). Both Hs2st / (Fig.
1D–F) and Hs6st1 / (Fig. 1G–I) em-
bryos have a gross neuronal/glial organi-
zation similar to wild-types, with Sox9
cells both in the VZ/GW and in a cluster
ventral to Tbr1/NeuN-expressing neuro-
nal cells in the IG region. However, in
bothmutants, the area occupied by Sox9
glial nuclei in the IG is wider and extends
further ventrally, suggesting that the ecto-
pic GFAP-expressing glial processes we
observed previously at the midline in these mutants stem from
increased numbers of glia in the IG region (more on this in Re-
sults, below; Conway et al., 2011a). There is no overlap between
Sox9 andNeuN/Tbr1 expression in any genotype, indicating that
the normal segregation between neuronal and glial cells in the IG
region is not disrupted in the mutants.
CCAs start to cross themidline at theCSB starting fromE16.5,
forming the U-shaped CC bundle by E17.5 (Richards, 2002). In a
series of coronal sections along the rostrocaudal axis spanning the
septumof E17.5wild-type embryos, theU-shapedCC is absent in
themost rostral sections (Fig. 2A) and present in themore caudal
sections (Fig. 2B,C; visible in sections stained with the nuclear
counterstain DAPI by virtue of low cell body density in the axon
bundle), whereasHs2st / andHs6st1 / embryos display PBs
in the caudal set of sections (Fig. 2F,G, J,K; Conway et al., 2011a).
We next determined how the distribution of Sox9 cells in the IG
region related to the normal formation of the CC in wild-type
embryos or the abnormal formation of PBs in Hs2st / or
Hs6st1 / embryos along the rostralCC/PB absent3 caudalCC/PB present
axis. In wild-type embryos, there are very few Sox9 cells in the
IG region of the most rostral sections (Fig. 2A), with more in
caudal sections dorsal to the CC (Fig. 2B,C). In both Hs2st /
(Fig. 2E) and Hs6st1 / (Fig. 2I) embryos, there are few Sox9
cells rostrally, as in the wild-type, but many more in caudal sec-
tions where PBs have formed (Fig. 2F,G, J,K). Sox9 cell counts
in evenly spaced serial sections from wild-type, Hs2st /, and
Hs6st1 / embryos allowed us to quantify the relationship be-
tween glial cell numbers in the IG and axon phenotype along the
rostrocaudal axis (Fig. 2M). In wild-type embryos (blue line in
Fig. 2M), the number of Sox9 cells was very low in the most
Figure 1. Similar gross organization of neuronal and glial cell bodies at the telencephalic midline in wild-type (A–C),
Hs2st / (D–F ), and Hs6st1 / (G–I ) embryos at E17.5. Shown is double immunofluorescence for Sox9 (green), which is
expressed in RGC and glial cell nuclei, and the postmitotic neuronal nuclear markers NeuN (red; A, B, D, E, G, H ) or Tbr1 (red;
C,F, I ). Nuclei inA,D, andG are counterstainedwithDAPI (blue). In all three genotypes,most Sox9 cells are located in theVZ and
at themidline,where they forma cluster ventral toNeuNor Tbr1neurons in the IG. Inwild-types, the IG Sox9 cell population
forms above the CC axon bundle, whereas in Hs2st / and Hs6st1 / embryos, it is sandwiched between the PBs. Box in A
indicates the region shown at highermagnification inB, C, E, F,H, and I. A,D, andG are to same scale; bar inG is 200m.B, C, E,
F, H, and I are to same scale, bar in I is 100m.
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Figure 2. Variations in the distribution of glial cells at the telencephalic midline in wild-type, Hs2st /, and Hs6st1 / embryos at E17.5. A–L, Sox9 immunofluorescence (green) at the
telencephalicmidline inwild-type (A–D),Hs2st / (E–H ), andHs6st1 / (I–L) embryos in rostral (A,E,I ),middle (B,F,J ), and caudal (C,D,G,H,K,L) coronal sections through the developing CC
region. Boxed region in A indicates the 250m 250m counting area encompassing the IG region used to generate data presented inM.M, Graph showing numbers of Sox9 nuclei in the IG
region counted in serial 10m sections spaced at 60m intervals along the rostrocaudal axis (mean SEM for WT, n 4 and Hs6st1 /, n 3; mean only for Hs2st /, n 2). The pink
box indicates the position of the CC (in wild-types) or PBs (in the mutants). Note that whereas midline Sox9 cell numbers increase moving caudally in all genotypes, the rate of increase is
dramatically greater in both mutants in association with PBs. D, H, L, Higher-magnification images of GW and IG region of C, G, and K, respectively. Note that in both (Figure legend continues.)
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rostral section, where the CC has not crossed the midline, and
rose to a plateau of80 cells/section starting at the rostral limit of
the CC (left end of the pink box on the x-axis in Fig. 2M) and to
150 cells/section toward the caudal end of the CC. In both
Hs2st / andHs6st1 / embryos (green and purple lines in Fig.
2M), there are very few Sox9 cells in the IG region rostrally and
numbers increase rapidly in successively more caudal sections,
where Sox9 cells in the IG region sit between the PBs (indicated
by pink box on x-axis in Fig. 2M), increasing to a maximum of
500 cells/section caudally. In summary, the numbers of glial cells
in the IG region follow a rostral low 3 caudalhigh trend in all
genotypes, coincidingwith the rostralno CC or PB3 caudalCC or PB present
transition, which is much more pronounced in association
with PBs in Hs2st / and Hs6st1 / embryos (compare blue
line with green and purple lines in Fig. 2M). We conclude that
Hs2st and Hs6st1 normally participate in a mechanism that re-
stricts the number of IG Sox9/glial cells and that the loss of
Hs2st or Hs6st1 function results in an increased number of IG
glia. Careful comparison of Sox9 expression at higher magnifica-
tion in the GW and IG of wild-type and
mutant embryos showed that a thick
Sox9 area at the GW faced a much
thinner Sox9 area at the IG in wild-
type embryos (Fig. 2D), whereas in both
mutants, there was a thinner Sox9 area
at the GW coinciding with a comple-
mentary enlarged Sox9 area at the IG
(Fig. 2H,L). These tectonic features
suggested that the overpopulated IG in
the mutants (Fig. 2M ) was at the ex-
pense of depleting the GW pool. Be-
cause Sox9 is expressed by both RGC
and glial nuclei in the GW and IG, we
first tested this hypothesis by counting
Sox9 cells in a radial strip (Fig. 2D)
spanning the GW3 IG. We found that
the total number of Sox9 cells in GW
 IG compartments was approximately
constant with 100 cells/section along
the rostrocaudal axis in all three geno-
types (Fig. 2N ). As predicted, Hs2st /
and Hs6st1 / embryos exhibited fewer
Sox9 cells remaining in the GW compart-
ment in themutants comparedwith thewild-
type (Fig. 2O), balancingmore Sox9 cells in
the IGcompartment of themutants (Fig. 2P).
This trend was apparent along the rostro-
caudal axis and was most pronounced
caudally, where the mutants had ap-
proximately half the number of Sox9
cells in the GW compartment and double the number of
Sox9 cells in the IG compartment compared with wild-types.
Mechanistically, because the IG is populated with glia by a
process of RGCs detaching their apical foot from the GW and
translocating their nuclei toward their basal foot in the IG, we
hypothesized that the change in the IG 7 GW distribution of
Sox9 cells in the mutants (Fig. 2) is caused by excessive move-
ment of Sox9 cells from the GW to the IG. Cells destined to
become IG glia are born in the GW around E14.5 and subse-
quently translocate to the IG (Shu et al., 2003a; Smith et al., 2006).
We labeled cells born at E14.5 using the thymidine analog BrdU,
which is incorporated into newly synthesized DNA during the
S-phase, and identified cells in this BrdU E14.5 birthdated co-
hort (red signal in Fig 3A–G), which contributed to the IG glial
population at E16.5 by virtue of nuclear colabeling with Sox9
(green signal in Fig. 3A–G), with colabeled BrdUSox9 nuclei
appearing yellow (Fig. 3A–C with IG region shown at higher
magnification in Fig 3E–G). In all genotypes, there are examples
of single-labeled Sox9, BrdU (green signal-glia not in birth-
dated cohort), Sox9, BrdU (red signal-birthdated cohort
which are not glia), and double-labeled Sox9Brdu (yellow
signal-birthdated cohort which are glia). Similar to E17.5 (Figs. 1,
2), there is a larger glial population at the IG in bothmutants than
in wild-type embryos (compare Fig. 3F,G, 3E). Quantification
confirmed that, in bothmutants, therewas an2-fold increase in
numbers of colabeled nuclei compared with wild-type embryos
(compare green and purple with blue bars in Fig. 3D), supporting
the hypothesis that there is excessive GW3 IG translocation of
glial cells inHs2st / andHs6st1 /embryos. Whereas, strictly
speaking, this conclusion only applies to the subpopulation of
cells that were labeled by our BrdU pulse protocol, we think it is
reasonable to extend it to the larger population of BrdU-
4
(Figure legend continued.) mutants, there is a thinning of the Sox9 area at the GW and
more Sox9 cells at the IG comparedwith thewild-type. Box inD showspositioningof 100m
wide radial strip used for quantification of numbers of Sox9 cells in the GW and IG compart-
ments inN–P. (N–P) Sox9 cell counts (mean SEM, n 3 for all genotypes) in the whole
strip (GWIG; N), the GW compartment (O), and the IG compartment (P) taken from serial
sections along the rostrocaudal axis binned into rostral,medial, and caudal segments (mean for
three sections for each bin). *ANOVA p	 0.05 followedby a post hoc Student’s t test formutant
versuswild-type comparison. The trend,most apparent caudally, is formore Sox9 cells at the
IG and fewer Sox9 cells in the GW in both mutants compared with the wild-type. Scale bars:
A–C, E–G, and I–K, 200m; D, H, and L, 100m.
Figure 3. Increased migration of glial cells from the GW to the IG in Hs2st / and Hs6st1 / embryos. (A–C, E–G) BrdU
(red) and Sox9 (green) immunofluorescence at the telencephalic midline of WT (A, E), Hs2st / (B, F), and Hs6st1 / (C, G)
embryos at E16.5 after a single BrdU administration at E14.5. E–G, Higher-magnification images of the IG region in A–C, respec-
tively. D, Quantification of the number of Sox9BrdU double-labeled cells (yellow) at the IG within a 250 m 250 m
counting area indicated in A. Histogram showsmean SEM: WT, n 4; Hs2st /, n 3; Hs6st1 /, n 4. *ANOVA p	
0.05 followed by a post hoc Student’s t test for mutant versus wild-type comparison. The number of double-labeled cells at the IG
is significantly increased in both Hs2st / and Hs6st1 / embryos compared with WT. H–J, PH3 immunohistochemistry
shows similar location of mitotic cells at the VZ of the GW in wild-type (H), Hs2st / (I), and Hs6st1 / (J) embryos and cell
counts (K) confirm a similar PH3 cell density in the GW region of the VZ between genotypes at E16.5. Histogram showsmean
SEM, n 3 for all genotypes. Scale bars: A–C and H–J, 100m; E–G, 50m.
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Sox9 glial cells that reached the IG by E16.5 but were not
undergoing S-phase during the BrdU pulse at E14.5.
The Sox9 cell counts already indicate that alterations to cell
proliferation or death are unlikely to account for the increased
numbers of Sox9 cells in the IG because there is no change in
total Sox9 cell numbers (Fig. 2N). Furthermore, we were un-
able to find any evidence for either (1) increased cell proliferation
before E17.5 contributing to the increase in midline glial cells in
themutants becausemitotic cells identified by phospho-histone3
(PH3) staining were restricted to the medial VZ encompassing
the GW in very similar numbers in all three genotypes at E16.5
(Fig. 3H–K) or (2) decreased apoptosis, as judged by cleaved
caspase-3 expression,whichwas similarly rare in theGW/IGof all
genotypes at E16.5 (data not shown).
Together, our data support amodel where increased numbers
of glia in the IG region, and the corresponding depletion of the
GW pool, of Hs2st / and Hs6st1 / embryos compared with
wild-types stem from excessive GW3 IG glial cell movements.
These results supply an explanation for our previous observation
that GFAP expression is reduced in the GW and enhanced in the
IG in these mutants and suggest that the large tangles of glial
processes at the mutant midline originate from an enlarged pop-
ulation of glial cell bodies located in an expanded IG (Conway et
al., 2011a).
Hs6st1suppressesFgf8protein levelsat the telencephalicmidline
The translocation of glia from the GW to the IG is regulated by
Fgf signaling. Blocking the Fgf pathway by abrogating Fgf recep-
tor function prevents glial cells from reaching the IG and, con-
versely, implanting Fgf8-soaked beads into the cerebral cortex
induces excessive translocation of RGCs to the pial surface, where
they differentiate into mature glia (Smith et al., 2006; Tole et al.,
2006). Therefore, the possibility of Fgf8 overexpression as a plau-
siblemechanism to explain theHs2st / and/orHs6st1 / glial
phenotype was examined in more detail. Western blotting of
protein extracted from whole telencephalon of E16.5 wild-type,
Hs2st /, and Hs6st1 / embryos showed that although there
was no difference in global Fgf8 protein levels between wild-type
and Hs2st / embryos, there was a marked 2-fold increase in
Hs6st1 / embryos (Fig. 4A). Immunofluorescence showed
that, at this stage, Fgf8 protein was mainly located in the extreme
ventral region of the medial telencephalon and either
absent or below detection threshold elsewhere in wild-type and
Hs2st / telencephalon (Fig. 4B,E,C,F). In contrast, Fgf8 pro-
tein was detected much more dorsally adjacent to the GW/IG in
Hs6st1 / embryos (Fig. 4D,G). The use of this Fgf8 antibody in
mice has been widely published (Dobrowolski et al., 2009; Lania
et al., 2009; Toyoda et al., 2010; Crespo-Enriquez et al., 2012) and
we confirmed its specificity in our hands by demonstrating spe-
cific staining of Cos7 cells transfected with an Fgf8 cDNA expres-
sion construct (compare Fgf8 transfected cells in Fig. 4H with
untransfected controls in Fig. 4I) and by taking advantage of the
severely hypomorphic Fgf8neo allele (Meyers et al., 1998) to con-
firm that the immunofluorescence signal was undetectable in
sections taken from Fgf8neo/neo embryos (Fig. 4J). We next inves-
tigated whether the changes in Fgf8 protein levels and distribu-
tion in Hs6st1 / embryos stem from changes in Fgf8 mRNA
levels or distribution. qRT-PCR analysis comparing RNA ex-
tracted fromwild-type andHs6st1 /medial telencephalon (en-
compassing the septum and medial cerebral cortex) revealed no
significant differences in Fgf8mRNA levels (Fig. 4K) and in situ
hybridization shows that Fgf8mRNA expression is most promi-
nent in the GW and IG of both wild-type and Hs6st1 / em-
bryos, with no obvious difference in its distribution (compare
Fig. 4L, 4M). Together, these data indicate that Hs6st1 acts on
Fgf8 via a posttranscriptional mechanism. In conclusion, the
GW/IG region is exposed to higher levels of Fgf8 protein in
Hs6st1 / embryos than in the other gentoypes, revealing an
unexpectedly specific role for Hs6st1 in suppressing levels of Fgf8
protein and suggesting amolecularmechanism for the glial trans-
Figure 4. Fgf8 protein and mRNA expression in the telencephalon at E16.5 in wild-type,
Hs2st /, and Hs6st1 / embryos. A, Western blot of telencephalic protein and quantifi-
cation for Fgf8 proteinwith-actin protein used for normalization. Histograms showsmean
SEM for WT, n 7; Hs2st /, n 4, Hs6st1 /, n 3. *ANOVA p	 0.05 followed by a
post hocStudent’s t test formutant versuswild-type comparison.B–G, Immunofluorescence for
Fgf8 (red) on coronal sections. Boxed areas inB–D shown at highermagnification in E–G. Fgf8
protein levels are much higher at the telencephalic midline of Hs6st1 / embryos compared
with the other genotypes. H, I, COS7 cells transfected with a mouse Fgf8 cDNA expression
construct showspecific immunofluorescent staining (H),whereas untransfected cells donot (I).
J, Fgf8 immunofluorescence is below detection limit in Fgf8 neo/neo-matched telencephalic tis-
sue homozygous for a severely hypomorphic Fgf8 allele. K, qRT-PCR analysis of RNA extracted
from the medial telencephalon shows no significant difference in Fgf8 mRNA expression be-
tween WT and Hs6st1 / embryos. Histograms shows mean  SEM for WT, n  5;
Hs6st1 /, n 4. L,M, In situ hybridization shows that in bothWT (L) and Hs6st1 / (M)
embryos Fgf8 mRNA is similarly localized to the IG and GW and expressed below detection
threshold elsewhere in the telencephalon. Scale bars:B–G and J–M, 200m; I and J, 100m.
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location phenotype inHs6st1 / embryos. In contrast, Fgf8 pro-
tein levels are unaltered in Hs2st / embryos, indicating that
Hs2st and Hs6st1 have distinct molecular roles.
Hyperactive Erk signaling coincides with the CC phenotype in
Hs2st / andHs6st1 / embryos
Fgf8 signals through the Erk pathway. The final step of this sig-
naling cascade involves the phosphorylation of Erk by Mek1/2
kinases to generate the transcriptionally active phospho-Erk
(pErk). We therefore examined the possibility that elevated Fgf8
levels in Hs6st1 / embryos in the developing telencephalon
(Fig. 4) might overstimulate the Erk pathway (Thisse and Thisse,
2005; Borello et al., 2008; Iwata andHevner, 2009; Guillemot and
Zimmer, 2011; Toyoda et al., 2010). First, we usedWestern blot-
ting to quantify the levels of pErk (normalized to levels of-actin
in the same blot) in the telencephalon of E16.5 wild-type,
Hs2st /, and Hs6st1 / embryos and discovered a robust
trend: wild-type 	 Hs2st / 		 Hs6st1 / with a 2-fold in-
crease in Hs2st / and a 6-fold increase in Hs6st1 / geno-
types, respectively (Fig. 5A). We confirmed that this was not a
consequence of a general increase in the levels of Erk protein in
the mutants by quantifying levels of total Erk (normalized to
levels of -actin in the same blot), which showed that Erk levels
were similar between genotypes, although there was a small but
significant decrease in Hs2st / embryos (Fig. 5B). Consistent
with previous reports, immunohistochemistry showed that, in
wild-type embryos, pErk is most abundant in cells in the VZ of
the lateral telencephalon at the pallial-subpallial boundary
(PSPB) and forms a PSPBhigh3 CSBlow gradient in the cerebral
cortex from the PSPB (open arrowhead in Fig. 5C) to the GW at
the CSB (filled arrowhead in Fig. 5C; Faedo et al., 2010). The
overall pattern is rather similar in Hs2st / embryos, although,
consistent with the Western blot data, the staining is stronger
(Fig. 5D). In Hs6st1 / embryonic telencephalon, there is a
global increase in pErk compared with wild-types, which is par-
ticularly apparent medially, where pErk levels are normally low-
est and the PSPBhigh 3 CSBlow gradient is flattened (compare
relatively uniform staining in cerebral cortex between open and
filled arrowheads in theHs6st1 / telencephalon in Fig. 5Ewith
thewild-type in Fig. 5C).Highermagnification shows that pErk is
detectable in some GW cells in all three genotypes (Fig. 5F–H;
arrows indicate highest expressing cells in each panel), withmany
cells exhibiting nuclear localization, suggesting that pErk is reg-
ulating nuclear gene transcription. In the wild-type GW, cells
expressing detectable levels of pErk make up a relatively small
subpopulation of the total (Fig. 5F). In the Hs2st / GW (Fig.
5G) and the Hs6st1 / GW (Fig. 5H), there are more pErk-
expressing cells and individual cells express higher levels of pErk
than in the wild-type (compare staining intensity in individual
cells indicated by arrows in Fig. 5F with that in Fig. 5G,H). This
effect ismore pronounced in theHs6st1 /GW,which is packed
with cells expressing high levels of pErk, than the Hs2st / GW
(compare Fig. 5G,H), although the levels of pErk within cells
appears similar (compare staining intensity of individual cells
indicated by arrow in Fig. 5G with that in Fig. 5H ). The
Hs6st1 / 

 Hs2st / 
 wild-type pErk expression trend
persists at E17.5 both globally (Fig. 5I–K ) and in GW cells
(Fig. 5L–N ). In conclusion, there is a striking increase in pErk
in GW cells in Hs6st1 / and Hs2st / embryos, with the
amount of deregulation correlating well with the severity of
the glial phenotype.
Bmp andWnt signaling are not grossly altered in E16.5
Hs2st / andHs6st1 / telencephalon
We next investigated whether perturbation to the Wnt or Bmp
pathways might contribute to the Hs2st / and Hs6st1 / CC
phenotypes. Western blotting of protein extracted from whole
telencephalon revealed that Lef1 (a readout of Wnt/-catenin
signaling; Hovanes et al., 2001; Filali et al., 2002; Fotaki et al.,
2013) protein levels did not vary between genotypes (Fig. 6A) and
phosphorylated Smad (pSmad1/5, a readout of Bmp signaling)
protein levels showed a weak trend of wild-type 	 Hs2st / 	
Hs6st1 / with a 1.5-fold increase in Hs6st1 / telencephalon
(Fig. 6A). Immunohistochemistry showed that the distribution
Figure 5. Erk signaling in the embryonic telencephalon in wild-type, Hs2st /, and
Hs6st1 / embryos at E16.5 (A–H) and E17.5 (I–N).A,Western blot for pErk1/2 and-actin
(loading control) in protein extracted fromwhole telencephalon, quantification shows pErk1/2
levels relative to-actin. pErk1/2 expression is significantly increased in both Hs2st / and
Hs6st1 / embryos compared with wild-type. B, Western blot for total Erk1/2, and-actin
(loading control) shows no increase in Erk1/2 expression in either Hs2st / or Hs6st1 /
embryos. Histograms in A and B show mean  SEM for WT, n  7; Hs2st /, n  4,
Hs6st1 /,n 3. *ANOVA p	 0.05 followedby a post hoc Student’s t test formutant versus
wild-type comparison. C–N pErk1/2 immunohistochemistry on (C–H) E16.5 and (I–N) E17.5
coronal section fromwild-type (C, F, I, L), Hs2st / (D,G, J,M), and Hs6st1 / (E,H, K,N)
embryos. Arrowheads in C–E, demarcate the cerebral cortex from the GW at the CSB (filled
arrowhead) to the PSPB (unfilled arrowhead). F–H and L–N are higher magnifications of the
GW area in C–E and I–K. Both mutants exhibit a global increase in pErk1/2 compared with
wild-type, which is particularly striking at the telencephalic midline, where levels are relatively
low in wild-type embryos. Within the GW, a larger number of pErk1/2-positive cells (examples
indicated by arrows) can be seen in the Hs2st / (G,M), which is even more pronounced in
the Hs6st1 / (H, N) compared with WT (F, L). Scale bars: C–E and I–K, 200m; F–H and
L–N, 20m.
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of Lef1 (compare Fig. 6B,D,F) and pSmad1/5 (compare Fig.
6C,E,G) were very similar between wild-type and mutant em-
bryos at the telencephalic midline. In summary, we were unable
to find evidence for major perturbation to theWnt or Bmp path-
ways in Hs2st / or Hs6st1 / telencephalon coinciding with
the CC phenotype.
Genetic or pharmacological suppression of Fgf8/Erk axis
components ameliorates theHs6st1 / phenotype
The data suggest that the Hs6st1 / phenotype stems from hy-
peractivation of the Fgf8/Erk axis causing excessive GW 3 IG
glial cell translocation and preventing CCAs navigating the mid-
line. We reasoned that if this is the case, then suppressing com-
ponents of the Fgf8/Erk pathway would rescue both glial and
axonal CC phenotypes.
First, we used a genetic approach to reduce gene dosage of Fgf8
from two (Fgf8/) to one (Fgf8/) functional alleles in
Hs6st1 / embryos. These experiments were performed on an
F2 CBA C57BL/6J genetic background and we were careful to
control for effect of genetic background (seeMaterials andMeth-
ods). Comparison of phenotype frequencies between the
Hs6st1 /;Fgf8/ and Hs6st1 /;Fgf8/ genotypes at E18.5
showed allHs6st /;Fgf8/ embryos (13/13 embryos; Fig. 7A)
and two-thirds of Hs6st1 /;Fgf8/ embryos (5/7 embryos;
Fig. 7B), with the severe Hs6st1 / CC phenotype manifesting
GFAP-expressing ectopic midline glia (green) and L1-expressing
PBs (red), as described previously (Conway et al., 2011a). Con-
sistent with our hypothesis, the remaining Hs6st1 /;Fgf8/
embryos (2/7 embryos; Fig. 7C) displayed a remarkably complete
rescue with appropriately positioned GFAP expressing GW and
IG glia (green) and a smooth L1-expressing U-shaped CC (red)
indistinguishable from wild-type embryos (Fig. 7D).
Next, we used a pharmacological approach to target the Erk-
activating kinaseMek inHs6st1 / embryos. These experiments
were performed on the CBA background for which we originally
described the Hs6st1 / phenotype (Conway et al., 2011a). Erk
signaling is hyperactive in mice harboring mutations in the Erk-
inhibitor Nf1 and these mice have brain abnormalities that are
rescued by treating with the potent and specificMek1/2 inhibitor
(MEKi) PD0325901 (Wang et al., 2012).We used the sameMEKi
dosage and treated pregnant females from Hs6st1/ 
Hs6st1/ crosses daily with MEKi between E14.5 and E17.5 to
span the period of normal and abnormal CC formation (Shu et
al., 2003a; Smith et al., 2006; Conway et al., 2011a). Immunoflu-
orescence for L1 (red) and GFAP (green) showed that all
Hs6st1 / embryos from uninjected (10/10 embryos; Fig. 7E) or
mock injected (vehicle with no MEKi) dams (3/3 embryos; Fig.
7F) have severe Hs6st1 / CC phenotype that we have consis-
tently seen on the CBA genetic background (Conway et al.,
2011a). In stark contrast, whereas approximately half the
Hs6st1 / embryos recovered fromMEKi-injected dams exhib-
ited the full CC phenotype (4/7 embryos; Fig. 7H), the remainder
displayed a complete phenotype rescue (3/7 embryos; Fig. 7G)
with complete restoration of GFAP expressing glia to their nor-
mal positions and the recovery of the L1-expressing U-shaped
CCA bundle. We next quantitatively tested the prediction that
the rescue of theHs6st1 / CC followed from the restoration of
the GW7 IG glial balance. At E18.5, similar to E17.5 (Fig. 2),
wild-type embryos have a thick area of Sox9 cells at the GW
facing a relatively small number of Sox9 cells at the IG (Fig. 7I)
and untreated Hs6st1 / embryos have a much thinner zone of
Sox9 at the GW andmore Sox9 cells at the IG (Fig. 7J). MEKi
treatedHs6st1 / embryos displaying the full rescue phenotype
(Fig. 7K) showed a Sox9 cell distribution closely resembling
wild-types (Fig. 7I) with a thick zone of Sox9 cells in the GW
facing fewer Sox9 cells in the IG. Counts of Sox9 cells in the
GW and IG regions along the rostrocaudal axis (following the
same protocol used in Fig. 2) revealed that although the Hs6st1
genotype and MEKi treatment did not affect the total number of
Sox9 cells along the GW3 IG path (Fig. 7L), Hs6st1 / em-
bryos in which the CC had been rescued by MEKi treatment had
approximately twice the number of Sox9 cells in the GW (Fig.
7M) and half the number of Sox9 cells in the IG (Fig. 7N) as
Hs6st1 / embryos that had been vehicle injected and displayed
the severe CC phenotype. In fact, the GW and IG counts for
MEKi-treated rescued Hs6st1 / embryos (red lines in Fig.
7M,N) were very similar to those for wild-type embryos (blue
lines in Fig. 7M,N) in contrast to vehicle-injected (unrescued)
Hs6st1 / embryos (purple lines in Fig. 7M,N). These data
strongly support the hypothesis that repressing the Erk pathway
inHs6st1 / embryos restores the wild-type GW7 IG glial cell
Figure 6. Lef1 and pSmad1/5 protein expression in the embryonic telencephalon of wild-
type,Hs2st /, andHs6st1 / embryos at E16.5.A,Westernblots for Lef1, pSMAD1/5, and
-actin (loading control) in protein extracted fromwhole telencephalon. Quantification shows
relative protein expression relative to-actin level. Note that Lef1 and pSMAD1/5 were quan-
tified in separate blots, which were each simultaneously probed with-actin. Lef1 expression
appears unchanged in both Hs2st / and Hs6st1 / embryos compared with wild-type.
pSMAD1/5 expression is slightly increased in Hs2st / embryos compared with wild-type
and is significantly increased in Hs6st1 / embryos compared with wild-type. Histograms
showsmean SEM forWT, n 4;Hs2st /, n 4,Hs6st1 /, n 4. *ANOVA p	 0.05
followed by a post hoc Student’s t test formutant versuswild-type comparison.B–G, Immuno-
histochemistry for Lef1 (B,D, F) andpSMAD1/5 (C,E,G) at E16.5 on coronal section ofwild-type
(B, C),Hs2st / (D, E), andHs6st1 / (F,G) telencephalon. The expression pattern of both
Lef1 and pSMAD1/5 at the telencephalic midline appears similar in WT, Hs2st /, and
Hs6st1 / embryos. Scale bar, 200m.
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Figure7. Rescue of theHs6st1 / CCphenotype by repressing the Fgf8/Erk axis.A–D, Reducing Fgf8genedosage ameliorates theHs6st1 / CCphenotype.A–C,Hs6st1 /;Fgf8/ (A)
andHs6st1 /;Fgf8/ (B,C) embryos inwhichB showsa completely unrescuedandCa completely rescuedHs6st1 /phenotype.D,WT (Hs6st1/;Fgf8/) control embryo. 24.13,
df 1; p	 0.05. E–N, MEKi treatment ameliorates the Hs6st1 / CC phenotype. Hs6st1 / embryos from Hs6st1/  Hs6st1/ crosses from uninjected (E), vehicle-injected (F), and
MEKi-injected dams (G,H), in whichH shows a completely unrescued and G a completely rescued Hs6st1 / phenotype. 2 6.55, df 1; p	 0.05. A–H show immunofluorescence for the
axonalmarker L1 (red) and theglialmarker GFAP (green) in coronal sections at E18.5. Numbers at the bottom left indicate theproportions of embryoswith phenotype shown in that panel. I–N, Sox9
immunofluorescence at E18.5 on wild-type uninjected embryos (I), Hs6st1 / vehicle-injected embryos with severe Hs6st1 / CC phenotype (J), and Hs6st1 / MEKi-injected embryos
showing a rescue of the CC phenotype (K). Box in I shows positioning of 100-m-wide radial strip used for quantification of numbers of Sox9 cells in the GW and IG compartments in L–N. L–N,
Sox9 cell counts in thewhole strip (GWIG; L), theGWcompartment (M), and the IG compartment (N) taken fromserial sections along the rostrocaudal axis binned into rostral,medial, and caudal
segments (mean for three sections for each bin). Plots shows mean SEM, n 3 for all conditions. *ANOVA p	 0.05 followed by a post hoc Student’s t test for MEKi (rescue) versus vehicle
comparison. The total number of Sox9-stained cells along thewhole strip is similar in theWT, vehicle, andMEKi groups (L). Sox9 cell number at the GW region is reduced in the vehicle-injected
Hs6st1 / embryos, but is returned to WT level in rescued MEKi-treated Hs6st1 / embryos (M). Sox9 cell number at the IG is increased in vehicle-injected Hs6st1 / embryos, but is
returned to WT level in rescued MEKi treated Hs6st1 / embryos (N). Scale bars, 200m.
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balance by damping excessiveGW3 IG translocation and allows
the development of a normal CC. The amelioration of the
Hs6st1 / CC phenotype by suppressing the Erk pathway from
E14.5 on establishes that elevated Erk signaling after E14.5, as
opposed to an irreversible change occurring before E14.5, is a
primary cause of the Hs6st1 / phenotype and identifies a 3 d
window during which Hs6st1 activity must keep Erk signaling in
check for normal CC development to proceed.
In conclusion, independent treatment strategies to antagonize
the Fgf8/Erk pathway genetically or pharmacologically produced
strikingly similar effects on bothHs6st1 /CCphenotype sever-
ity and penetrance. Approximately one-third (5/14) of treated
embryos exhibited a full rescue and the remaining two-thirds
(9/14) exhibited no rescue at all compared with a fully penetrant
severe phenotype in all (26/26) untreated Hs6st1 / embryos
(2 10.61, df 1; p	 0.01). It is noteworthy that either both or
neither axon and glial phenotypes were rescued andwe never saw
abnormal axonswith normal glia or vice versa in any (0/14) of the
rescue experiment embryos examined.
Discussion
Our salient findings are as follows: (1) the loss of either Hs2st or
Hs6st1 function alters the telencephalic midline glial environ-
ment by allowing excess GW 3 IG glial cell movement; (2)
Hs6st1 posttranscriptionally suppresses the levels of Fgf8 protein
levels in the GW/IG region; (3) Hs6st1, and to a lesser extent,
Hs2st suppress the Erk signaling pathway in the telencephalon
including at the GW; and (4) repressing the Fgf8/Erk axis rescues
the Hs6st1 / CC phenotype. These data suggest a model in
which, in wild-type embryos, pErk levels are tightly regulated,
with Hs2st and Hs6st1 playing important repressor functions to
generate the right levels of pErk to drive the right amount of GW
3 IG glial translocation and generate the GW 7 IG glial cell
balance needed to guide CCAs across the midline (Fig. 8A). The
loss of either Hs2st (Fig. 8B) or Hs6st1 (Fig. 8C) repressor func-
tion elevates pErk above normal levels, causing excessive GW3
IG glial translocation and preventing CCAs from crossing the
midline. Conversely, repressing the hyperactive Erk pathway in
an Hs6st1 / embryo restores the normal GW 7 IG glial cell
balance and CCA midline crossing (Fig. 8D).
The Erk pathway is one of four mitogen-activated protein
kinase (Mapk) cascades that transduce extracellular signals into
the cell. At the core of Erk signaling pathway are the two Erk
kinases, Erk1 and Erk2, the phosphorylation of which byMek1/2
kinases activates Erk kinase activity and regulation of gene ex-
pression, cell proliferation, migration, differentiation, and/or
death (Rubinfeld and Seger, 2005). Both gain- and loss-of-
function mutations in ERK pathway components in humans
have been linked to a wide spectrum of phenotypes spanning
developmental processes (Samuels et al., 2009). Genetically stim-
ulating the Erk pathway during mouse cerebral cortex develop-
ment with constitutively activeMek or inactiveNf1 alleles causes
precocious glial output, whereas suppressing Erk by inactivating
Mek has the opposite effect, both without changes in cell prolif-
eration or apoptosis (Li et al., 2012; Pucilowska et al., 2012;Wang
et al., 2012). The increased numbers of mature glia at the
telencephalic midline of both Hs2st / and Hs6st1 / em-
bryos with no obvious associated changes in cell proliferation
resembles these models (Conway et al., 2011a; present study).
Knock-out of the Erk inhibitors Sprouty1/2 also elevates Erk
signaling and causes midline glial tangles with CC agenesis,
although Sprouty1/2 / embryos additionally exhibit in-
creased cell proliferation, which may contribute to the glial
output (Faedo et al., 2010; Magnani et al., 2014). The spec-
trum of phenotypes inHs6st1,Mek,Hs2st,Nf1, and Sprouty1/2
mutant models that share Erk hyperactivation likely stems
from differences in Erk and non-Erk pathway disturbance and
spatiotemporal activity.
A clear implication of our study is that the correct GW7 IG
balance of glia must bemaintained at an optimal level for normal
CCdevelopment. Here, we addressed Erk hyperactivation result-
ing in excessive GW3 IG glial translocation and CC agenesis.
Fgf receptor null mutations, which would be expected to in-
hibit the Erk pathway, have the opposite effect and inhibit GW
3 IG glial translocation but also produce CC agenesis (Tole et
al., 2006, Smith et al., 2006). The overall cellular picture that
Figure 8. Model summarizing cellular and molecular phenotypes of Hs2st / and Hs6st1 / embryos at the telencephalic midline. A, In WT embryos, Hs6st1 and (to a lesser extent) Hs2st
activities both repress the Erk signaling pathway tomaintain a level of pErk that drives appropriate numbers of Sox9 glia (green) to translocate (pink arrows) from the GW to the IG and generates
a GW7 IG glial balance that guides CCAs (red arrow) across the telencephalicmidline in 100%of embryos. Loss of Hs2st (B) or Hs6st1 (C) activity results in a derepression of the Erk pathway, excess
levels of pErk in the GW, and excess GW3 IG translocation of Sox9 glia-blocking (red X) CCAs from crossing the telencephalic midline. The Hs2st / and Hs6st1 / phenotypes differ
quantitatively, with Hs2st / embryos exhibiting 2-fold Erk hyperactivation and50% of embryos developing a normal CC and Hs6st1 / embryos exhibiting 6-fold Erk hyperactivation and
0%developinganormal CC.D, Repressing thehyperactive Erkpathway inHs6st1 /embryos restores theGW7 IGglial balanceandameliorates the severity andpenetranceof theCCphenotype,
with33% of embryos developing a normal CC using the treatments used in this study. Thickness of “T” symbol indicates repressor strength and size of pErk text indicates pErk levels in each
genotype. Numbers at bottom indicate proportion (%) of embryos of each condition that produce a normal CC.
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emerges is of a finely poised system in which the correct GW
7 IG balance of glia, itself dependent on a narrow range of Erk
signaling levels, is needed to shepherd axons across the telen-
cephalic midline.
In humans, hypomorphic mutations in HS6ST1 have been
linked to the pituitary developmental disorder idiopathic hy-
pogonadotrophic hypogonadism (IHH), as have loss-of-
function mutations in FGF8 and FGFR1 (Tornberg et al.,
2011). Interestingly, FGFR1mutations enhance the IHH phe-
notype in patients harboring HS6ST1 mutations, suggesting
that, in the human IHH context, HS6ST1 positively regulates
FGF signaling. How theHS6ST17 FGF8 interaction relates to
ERK signaling in IHH is unknown, but contrasts with the
antagonistic Fgf8 7 Hs6st1 genetic interaction that we have
described here in the mouse and indicates species- and/or
tissue-specific interaction.
Classically, HS acts as a coreceptor with Fgfrs for Fgfs and
regulates Fgf diffusion kinetics (Schlessinger et al., 2000; Harmer,
2006; Yu et al., 2009; Guillemot and Zimmer, 2011; Duchesne et
al., 2012). Fgf signaling during the development of the mouse
forebrain is a complex and dynamic procedure,marshalling Fgf2,
Fgf3, Fgf7, Fgf8, Fgf15, Fgf17, and Fgf18 ligands and Fgfr1, Fgfr2,
and Fgfr3 receptors that signal through a combination of Erk and
non-Erk pathways (Thisse and Thisse, 2005; Borello et al., 2008;
Iwata andHevner, 2009; Guillemot andZimmer, 2011; Toyoda et
al., 2010). Puzzlingly, in contrast to the Erk hyperactivation that
we see in Hs2st / or Hs6st1 / telencephalon, the consensus
of other studies in whichHS biosynthesis is perturbed genetically
is hypoactive Fgf/Erk signaling attributed to excessive diffusion
diluting Fgf ligands below activation threshold and/or weak Fgf/
Fgfr binding, rendering cells unresponsive to Fgf (Qu et al., 2011;
Shimokawa et al., 2011; Qu et al., 2012). We suspect major per-
turbations imposed on HS by genetic ablation of the core HS
biosynthetic Ext enzymes, which abolish HS synthesis altogether,
or of multiple HS-modifying enzymes simultaneously maximize
gross changes in, or even complete loss of, HS sulfation and this is
why we see a different class of phenotype in our single mutation
Hs2st / and Hs6st1 / embryos, which would be expected to
have less perturbed HS (Inatani et al., 2003; Qu et al., 2011;
Shimokawa et al., 2011; Qu et al., 2012). Perhaps analogously, a
missense mutation in Fgf9, which changes its interaction kinetics
withHS and ectopically activates Fgf9 targets, causes a completely
different bone phenotype to null Fgf9 alleles which have no sig-
naling activity (Harada et al., 2009).
We found a striking correlation between Erk hyperactivity
and CC phenotype penetrance (summarized in Fig. 8A–D).
Hs6st1 / embryos have greater Erk hyperactivation and higher
penetrance thanHs2st / embryos and treatments that suppress
Fgf8/Erk axis components inHs6st1 / embryos reduceCCphe-
notype penetrance. Matched Hs6st1 / embryonic littermates
sharing the same amount of drug from thematernal bloodstream
and/or the same genetic background, aswell other environmental
factors, were either fully rescued or not rescued at all, suggesting
a more interesting explanation than suboptimal rescue treat-
ment. Our data imply a surprisingly binary “on/off” switch prop-
erty of this system in which genetic and environmental factors,
channelling through Erk after E14.5, fix the probability of the CC
developing normally. Mechanistically, we suspect that Erk con-
trols gene expression programs governing an initiation event in-
volving a small number of cells critical for the subsequent fate of
manymore cells duringCCdevelopment.How thismightwork is
uncertain but plausible scenarios include pioneer effects in which
once one or a few axons manage to cross the midline, likely in
close association with glia, this seeds the formation of the whole
CC structure via cell7 cell interaction mechanisms such as fas-
ciculation. Consistent with this idea, we always see an extremely
tight linkage between glial and axonal phenotypes in the Fgf8/Erk
Hs6st1 / rescue experiments (14/14 embryos in which neither
or both axons and glia attain normal CC configuration). This
tight linkage can be broken in other situations as axon and glial
phenotypes are uncoupled in Hs6st1 /;Slit2 / embryos in
which removal of Slit2 allows axons to burrow through ectopic
glia at themidline (Conway et al., 2011a). These and other studies
point to glialmispositioning (caused by Erk) as the primary cause
and the noncrossing axon phenotype (caused by Slit2 expressed
by mispositioned glia) as a secondary consequence in the
Hs6st1 /, and likely the Hs2st /, phenotype (Bagri et al.,
2002; Shu et al., 2003b; Smith et al., 2006; Conway et al., 2011a).
However, because the full extent of Erk 7 glia 7 axon causal
relationships during CC development are not fully understood,
there are additional possibilities worth exploring in the future.
CC axonsmay influence the glial phenotype and/or various com-
binations of Hs2st, Hs6st1, Fgf8, and Erk and other factors may
contribute directly to both axon and glial phenotypes.
Here, we identify distinct molecular roles for Hs2st and
Hs6st1 in the developingmammalian telencephalon.Hs6st1 sup-
presses levels of Fgf8 protein posttranscriptionally and has a large
negative effect on pErk levels, whereas Hs2st does not suppress
levels of Fgf8 protein and has a smaller negative effect on pErk. All
of this fits the “sugar code” idea that Hs2st and Hs6st1 each
instruct HS to function in a molecularly distinct manner. For-
mally testing this hypothesis in our system awaits the develop-
ment of more sensitive glycomic technologies to reveal how the
fine structure of HS, ideally at the cellular level, correlates with
normal and abnormal CC development. Alternative explana-
tions, for example, that the distinct Hs2st / and Hs6st1 /
phenotypes reflect different sites of action of the two enzymes,
also need to be investigated because, in other systems, there is
genetic evidence that Hs2st and the three mammalian Hs6st
isoforms have redundant functions and/or are able to com-
pensate for one another’s function, arguing against Hs2st and
Hs6st imparting unique molecular instructions onto HS in all
situations (Kamimura et al., 2006; Qu et al., 2011; (Conway et
al., 2011b). In light of all of these unanswered questions, the
nonredundant roles we find for Hs2st and Hs6st1 during CC
development provide a powerful experimental system for de-
ciphering the roles of Hs2st and Hs6st1 in the sugar code or
establishing an alternative model to account for their distinct
genetic functions.
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